C. Dieulafoy’s disease of the bronchus
Discussion
This patient’s acute onset hemoptysis and findings on bronchoscopy
and angiogram are consistent with Dieulafoy’s disease of the bronchus.
Histoplasmosis typically presents with fever, myalgias, cough, and chest
pain, which were absent in this patient. CT findings in pulmonary
histoplasmosis include prominent lymphadenopathy and calcified lung
nodules (“histoplasmomas”). While bronchial carcinoid tumors and
arteriovenous malformations often present with hemoptysis, this
patient’s CT scan does not support these diagnoses. Her acute
presentation and lack of longstanding productive cough or CT findings
consistent with bronchiectasis make this diagnosis unlikely.
Dieulafoy’s disease refers to the presence of tortuous and dilated
arteries in the submucosa, usually in the gastrointestinal tract.
Rarely, these abnormal vessels can be present in the bronchial tree,
leading to massive hemoptysis and potentially fatal pulmonary
hemorrhage. Bleeding occurs when the blood vessel ruptures.1
Bronchial Dieulafoy’s disease (BDD) is extremely rare; according to one
review, only 73 cases were described worldwide between the years 1995 to
2019. Much of the literature on this entity consists of case reports.
Most reported cases have occurred in middle-aged adults. 2
In children, BDD is exceptionally rare; according to a recent review,
only 4 cases of pediatric BDD have been reported. These cases occurred
in children aged 8 months, 7 years, 13 years, and 16 years.2
The etiology of BDD has not been definitively established. A
significant association between BDD and smoking has been noted, and many
patients have underlying pulmonary disease. This has led to the
hypothesis that underlying chronic inflammation leads to vascular smooth
muscle hypertrophy, making the vessel tortuous and prone to rupture.
However, many believe that BDD is a congenital disease because it also
occurs in individuals without underlying conditions. The abnormal
bronchial artery is most often located entering the right main stem
bronchus, but in up to one-third of cases it supplies the left bronchus.
Most affected patients are brought to medical attention due to
hemoptysis. Other symptoms include cough, chest pain, and dyspnea.1
CT scan of the chest frequently shows ground glass opacities, however
imaging is often normal and cannot be relied upon for diagnosis.
Utilization of thoracic vascular CT angiography timed to examine both
the bronchial and pulmonary arteries can allow for visualization of the
abnormal vessels. Bronchoscopy most often shows a nodular appearing,
non-pulsatile lesion with a white “cap” that is < 1 cm in size.
However, a distinct lesion may be difficult to identify through
bronchoscopy, especially if the patient is actively bleeding or if the
lesion is in a more distal airway than can be visualized by the
bronchoscope. The lesions are often biopsied due to their resemblance to
tumors; however, biopsy should be avoided if suspicion for a tumor is
low, given the risk of precipitating massive and potentially fatal
hemorrhage.3 Angiography is helpful in identifying the course of the tortuous, dilated vessel.1
Prompt recognition and treatment are critical, as patients can
develop life threatening hemoptysis. No consensus exists on how to
manage patients with BDD. The most common strategy is bronchial artery
embolization (BAE), although it is associated with significant failure
rates. According to one review, approximately 52% of patients who
underwent BAE experienced recurrent hemoptysis and required lobectomy.
Therefore, it is vital for patients to be monitored after BAE for
recurrence of symptoms.4 Surgical management with
segmentectomy or lobectomy has been reported to be nearly 100%
successful in treating BDD. Other surgical approaches such as sleeve
resection have been used to preserve lung parenchyma.2
In this patient, interventional cardiology performed coil
embolization of two Dieulafoy lesions of the right bronchus. The patient
was monitored overnight in the pediatric intensive care unit and was
discharged home the next day. She had no further episodes of hemoptysis.
References
-
Chen W et al. Clinical characteristics and treatments for bronchial
Dieulafoy’s disease. Respiratory Medicine Case Reports 26 (2019) 229-235
-
Yeh YT et al. Bronchial Dieulafoy’s Disease in Children: A Case Report and Review of Literature. Frontiers in Pediatrics 8:273
-
Barisione et al. Dieulafoy’s disease of the bronchus: a possible mistake. Multidisciplinary Respiratory Medicine 2012, 7:40
-
Qian et al. Bronchial Dieulafoy’s disease: a retrospective analysis of 73 cases. BMC Pulmonary Medicine (2019) 19:104